Ep Biocomposites Limited

As of March 31, 2026, Ep Biocomposites Limited carries a market capitalization of 141.25M, placing it among publicly traded companies globally. Its enterprise value stands at 143.67M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Ep Biocomposites Limited has 1.68M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Ep Biocomposites Limited maintains a current ratio of 3.34, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, Ep Biocomposites Limited's stock has declined approximately 41.96% over the past 52 weeks. The 50-day moving average sits at 97.65, while the 200-day moving average is 108.54.

As of March 31, 2026, Ep Biocomposites Limited holds 21.54M in cash and equivalents against 23.96M in total debt, resulting in a net debt position of 2.42M. Total book value stands at 120.53M, with working capital of 110.23M providing operational flexibility.